Study Stopped
President Trump's Executive Order
Optimal Intervention to Full Viral Suppression: Text Me, Alexis!
Comparative- and Cost-effectiveness Research Determining the Optimal Intervention for Advancing Transgender Women Living With HIV to Full Viral Suppression
1 other identifier
interventional
71
1 country
1
Brief Summary
Text Me, Alexis! is a three-arm randomized controlled trial (RCT) to determine the optimal and most cost-effective intervention for advancing trans women living with HIV to full viral suppression. Participants will be randomized (1:1:1) to Peer Health Navigation (PHN) alone, SMS (text messaging) alone, or PHN+SMS. Participants in the PHN alone and PHN+SMS arms will receive unlimited navigation sessions over 3 months. Participants in the SMS alone and PHN+SMS arms will receive 3 daily theory-based text messages for 90 days for a total of 270 unique scripted messages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hiv
Started Apr 2024
Shorter than P25 for not_applicable hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 11, 2024
CompletedFirst Submitted
Initial submission to the registry
April 26, 2024
CompletedFirst Posted
Study publicly available on registry
May 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 19, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 19, 2025
CompletedFebruary 11, 2026
May 1, 2025
11 months
April 26, 2024
February 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Rate of HIV Viral Load Suppression
HIV virological suppression is defined as the undetectability threshold ˂200 copies/mL. Key indicators of HIV care will be regressed on treatment condition and a series of baseline and time-varying covariates. Responses at each timepoint will be considered nested within an individual, which is necessary to control for the violations of independence that can occur when repeated measurements are taken from the same individual.
18 months
Relative Cost Effectiveness
The primary outcome of the cost-effectiveness analysis is the incremental cost-effectiveness ratio (ICER), which will be calculated as the incremental mean cost of a given intervention relative to an alternative, divided by the incremental mean effectiveness of the two interventions. Two types of ICERs will be calculated, one for each measure of effectiveness: a) The quality-adjusted life-year (QALY) is a measure that combines the health-related quality-of-life (HRQoL) associated with an individual's health state and their time spent in that state, and b) Advancement along the HIV Care Continuum. All measures of mean cost and effectiveness will be adjusted for important covariates. Relative cost-effectiveness will be assessed according to multiple decision-maker perspectives, and will be evaluated across a range of willingness-to-pay thresholds.
18 months
Secondary Outcomes (1)
Measurements of Heterogeneous Intervention Effects
18 months
Study Arms (3)
Peer Health Navigation (PHN)
EXPERIMENTALPHN is a peer navigation intervention to advance trans women through the HIV Care Continuum by identifying their individual needs and barriers to HIV care, including: substance use and behavioral health needs; adherence goal(s); and methods to achieve adherence. Participants receive unlimited navigation sessions over 3 months; PHN sessions are delivered in a private room similar to a one-on-one peer counseling session.
Simple Message System (SMS [text messaging])
EXPERIMENTALText messages are scripted across: 1) HIV Care Continuum (HIV Positivity/Physical and Emotional Health, Linkage/Retention in HIV Care, and ART Adherence/Viral Load Suppression); and, 2) theoretical foundation (Social Support Theory, Social Cognitive Theory, or Health Belief Model). Participants receive three daily, theory-based text messages for 90 days (270 unique scripted messages), evenly arrayed across the HIV Care Continuum. Text messages are delivered and transmitted to either a cell phone or an email inbox.
PHN and SMS
EXPERIMENTALPHN + SMS is the combined intervention. PHN is a peer navigation intervention to advance trans women through the HIV Care Continuum by identifying their individual needs and barriers to HIV care, including: substance use and behavioral health needs; adherence goal(s); and methods to achieve adherence. Participants receive unlimited navigation sessions over 3 months; PHN sessions are delivered in a private room similar to a one-on-one peer counseling session. Text messages are scripted across: 1) HIV Care Continuum (HIV Positivity/Physical and Emotional Health, Linkage/Retention in HIV Care, and ART Adherence/Viral Load Suppression); and, 2) theoretical foundation (Social Support Theory, Social Cognitive Theory, or Health Belief Model). Participants receive three daily, theory-based text messages for 90 days (270 unique scripted messages), evenly arrayed across the HIV Care Continuum. Text messages are delivered and transmitted to either a cell phone or an email inbox.
Interventions
Determine the Optimal Intervention for Advancing Transgender Women Living with HIV to Full Viral Suppression
Eligibility Criteria
You may qualify if:
- Self-identified transgender woman;
- Age 18 or older;
- Verified HIV positive status;
- Not currently in HIV care, and/or had not had an HIV care visit in the previous 6 months, and/or had a viral load of ≥200 copies/ml on her last lab test result, and/or not currently prescribed ART, and/or prescribed ART but does not rate her ability to take all her medications as "excellent";
- Ability to receive daily text messages on either a personal cell phone or via an email account
You may not qualify if:
- Does not identify as a transgender woman;
- Under 18 years of age;
- HIV negative status;
- Currently in HIV care, and had a HIV care visit in the previous 6 months, and had a viral load of ≤200 copies/ml on her last lab test result, and currently prescribed ART, and rates her ability to take all her medications as "excellent";
- Does not have the ability to receive daily text messages on either a personal cell phone or via an email account.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Friends Community Center
Los Angeles, California, 90028, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Cathy J Reback, PhD
Friends Research Institute, Inc.
- PRINCIPAL INVESTIGATOR
Sean M Murphy, PhD
Weill Medical College of Cornell University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 26, 2024
First Posted
May 10, 2024
Study Start
April 11, 2024
Primary Completion
March 19, 2025
Study Completion
March 19, 2025
Last Updated
February 11, 2026
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share
No current plan to share individual participant data.